Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Cabre

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2019
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndromeNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Journal of Neurology|January 15, 2025
MOG antibody-associated disease epidemiology in Olmsted County, USA, and MartiniqueLaura Cacciaguerra, Elia Sechi, Isabelle Komla-Soukha, et al.
European Journal of Neurology|March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centersXavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring systemCamille Sabathé, Romain Casey, Sandra Vukusic, et al.
JAMA Network Open|October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated SyndromeChristine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2019
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndromeNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Journal of Neurology|January 15, 2025
MOG antibody-associated disease epidemiology in Olmsted County, USA, and MartiniqueLaura Cacciaguerra, Elia Sechi, Isabelle Komla-Soukha, et al.
European Journal of Neurology|March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centersXavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring systemCamille Sabathé, Romain Casey, Sandra Vukusic, et al.
JAMA Network Open|October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated SyndromeChristine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 8